Bank Of New York Mellon Corp Allogene Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$2.92 - $5.63 $68,409 - $131,899	-23,428 Reduced 7.23%	300,553 $1.34 Billion
Q4 2023 Jan 29, 2024	BUY	$2.28 - $3.5 $30,020 - $46,084	13,167 Added 4.24%	323,981 $1.04 Billion
Q3 2023 Oct 24, 2023	BUY	$3.17 - $5.96 $6,111 - $11,490	1,928 Added 0.62%	310,814 $985 Million
Q2 2023 Aug 03, 2023	SELL	$4.53 - $6.74 $187,011 - $278,247	-41,283 Reduced 11.79%	308,886 $1.54 Billion
Q1 2023 May 09, 2023	BUY	$4.92 - $8.21 $1.72 Million - $2.87 Million	350,169 New	350,169 $1.73 Billion
Q4 2022 Feb 14, 2023	BUY	$5.62 - $11.11 $1.73 Million - $3.43 Million	308,422 New	308,422 $1.94 Million
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $414,255 - $693,636	40,141 Added 16.16%	288,522 $3.12 Million
Q2 2022 Aug 15, 2022	SELL	$6.78 - $12.28 $344,871 - $624,634	-50,866 Reduced 17.0%	248,381 $2.83 Million
Q1 2022 May 11, 2022	BUY	$7.65 - $15.29 $4,352 - $8,700	569 Added 0.19%	299,247 $2.73 Million
Q4 2021 Feb 11, 2022	SELL	$13.13 - $24.52 $264,267 - $493,514	-20,127 Reduced 6.31%	298,678 $4.46 Million
Q3 2021 Nov 12, 2021	BUY	$21.01 - $27.64 $766,192 - $1.01 Million	36,468 Added 12.92%	318,805 $8.19 Million
Q2 2021 Aug 11, 2021	BUY	$23.49 - $35.8 $1.41 Million - $2.15 Million	60,187 Added 27.09%	282,337 $7.36 Million
Q1 2021 May 13, 2021	SELL	$25.79 - $39.02 $206,732 - $312,784	-8,016 Reduced 3.48%	222,150 $7.84 Million
Q4 2020 Feb 09, 2021	BUY	$25.24 - $43.45 $175,342 - $301,847	6,947 Added 3.11%	230,166 $5.81 Million
Q3 2020 Nov 12, 2020	SELL	$32.38 - $44.96 $165,461 - $229,745	-5,110 Reduced 2.24%	223,219 $8.42 Million
Q2 2020 Aug 12, 2020	BUY	$18.39 - $54.04 $1.28 Million - $3.76 Million	69,663 Added 43.91%	228,329 $9.78 Million
Q1 2020 May 06, 2020	BUY	$18.22 - $28.25 $37,824 - $58,647	2,076 Added 1.33%	158,666 $3.08 Million
Q4 2019 Feb 14, 2020	BUY	$24.82 - $31.4 $218,440 - $276,351	8,801 Added 5.96%	156,590 $4.07 Million
Q3 2019 Nov 07, 2019	BUY	$26.11 - $32.99 $364,991 - $461,167	13,979 Added 10.45%	147,789 $4.03 Million
Q2 2019 Aug 12, 2019	BUY	$25.56 - $31.09 $1.42 Million - $1.73 Million	55,743 Added 71.4%	133,810 $3.59 Million
Q1 2019 May 14, 2019	BUY	$24.82 - $32.54 $1.07 Million - $1.4 Million	43,099 Added 123.25%	78,067 $2.26 Million
Q4 2018 Feb 11, 2019	BUY	$22.5 - $33.3 $786,780 - $1.16 Million	34,968 New	34,968 $941,000

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $262M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account